Carsgen Therapeutics Limited (2171.HK) Q1 2025 Earnings

18MarConfirmed
Q2 2023
Q1 2024
Q3 2024
Q1 2025
-0.97
-0.74
-0.51
-0.28

Details

Expected EPS
-0.42562730496
Actual EPS
-0.861895292544
Surprise EPS
-0.44
Surprise Percent
+102.5%

Description

Carsgen Therapeutics Limited (2171.HK) has reported earnings of -0.861895292544 per share for Q1 2025.

0 Comments

Share your thoughts